AMP-activated protein kinase α2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function

Diabetes

Volumn 56, Issue 3, 2007, Pages 786-794

  Athéa, Yoni ^a,b,c   Viollet, Benoît ^d,e,f,g   Mateo, Philippe ^a,b,c   Rousseau, Delphine ^b,c,h   Novotova, Marta ⁱ   Garnier, Anne ^a,b,c   Vaulont, Sophie ^d,e,f,g   Wilding, James R ^a,b,c   Grynberg, Alain ^b,c,h   Veksler, Vladimir ^a,b,c   Hoerter, Jacqueline ^a,b,c   Ventura Clapier, Renée ^a,b,c  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Institut Fédératif de Recherche 141   (France)

^d INSTITUT COCHIN   (France)

^e INSERM   (France)

^f CNRS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h Natl Rech Sci Pharmacol C/M   (France)

ⁱ INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; FATTY ACID; GLUTAMIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA2; ISOENZYME; LINOLEIC ACID; MALIC ACID; MEMBRANE PHOSPHOLIPID; OCTANOIC ACID; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SAPONIN; SUCCINIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BODY WEIGHT; CELL FUNCTION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART WEIGHT; HOMEOSTASIS; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 33847420521     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0187     Document Type: Article

References (46)

1. Kahn BB, Alquier T, Carling D, Hardie DG: AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25, 2005
2. Fryer LG, Carling D: AMP-activated protein kinase and the metabolic syndrome. Biochem Soc Trans 33:362-366, 2005
3. Hardie DG, Scott JW, Pan DA, Hudson ER: Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546:113-120, 2003
4. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D: Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 346:659-669, 2000
5. Sambandam N, Lopaschuk GD: AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 42:238-256, 2003
6. Hue L, Beauloye C, Bertrand L, Horman S, Krause U, Marsin AS, Meisse D, Vertommen D, Rider MH: New targets of AMP-activated protein kinase. Biochem Soc Trans 31:213-215, 2003
7. Russell RR III, Bergeron R, Shulman GI, Young LH: Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643-H649, 1999
8. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L: Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10:1247-1255, 2000
9. Tian R, Musi N, D'Agostino J, Hirshman MF, Goodyear LJ: Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104:1664-1669, 2001
10. Coven DL, Hu X, Cong L, Bergeron R, Shulman GI, Hardie DG, Young LH: Physiologic role of AMP-activated protein kinase (AMPK) in the heart: graded activation during exercise. Am J Physiol Endocrinol Metab 285:E629-E636, 2003
11. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K: Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389, 2004
12. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH: AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114:495-503, 2004
13. Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF, Goodyear LJ, Tian R: Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha 2 subunit of AMP-activated protein kinase. J Biol Chem 278:28372-28377, 2003
14. Reznick RM, Shulman GI: The role of AMP-activated protein kinase in mitochondrial biogenesis. J Physiol 574:33-39, 2006
15. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R, Vaulont S: The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111:91-98, 2003
16. Zarrinpashneh E, Carjaval K, Beauloye C, Ginion A, Mateo P, Pouleur AC, Horman S, Vaulont S, Hoerter JA, Viollet B, Hue L, Vanoverschelde JL, Bertrand L: Role of the alpha2 isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am J Physiol Heart Circ Physiol 291:H2875-H2883, 2006
17. Hoerter J, Gonzalez Barroso MD, Couplan E, Mateo P, Gelly C, Cassard Doulcier AM, Diolez P, Bouillaud F: Mitochondrial uncoupling protein 1 expressed in the heart of transgenic mice protects against ischemic-reperfusion damage. Circulation 110:528-533, 2004
18. Novotova M, Pavlovicova M, Veksler V, Ventura-Clapier R, Zahradnik I: Ultrastructural remodeling of fast skeletal muscle fibers induced by invalidation of creatine kinase. Am J Physiol Cell Physiol 291:C1279-C1285, 2006
19. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA: Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta 892:191-196, 1987
20. Saks VA, Veksler VI, Kuznetsov AV, Kay L, Sikk P, Tiivel T, Tranqui L, Olivares J, Winkler K, Wiedemann F, Kunz WS: Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem 184:81-100, 1998
21. Bahi L, Koulmann N, Sanchez H, Momken I, Veksler V, Bigard AX, Ventura-Clapier R: Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol 96:59-64, 2004
22. Veksler VI, Kuznetsov AV, Anflous K, Mateo P, van Deursen J, Wieringa B, Ventura-Clapier R: Muscle creatine kinase-deficient mice. 2. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function. J Biol Chem 270:19921-19929, 1995
23. Ray S, Dutta S, Halder J, Ray M: Inhibition of electron flow through complex I of the mitochondrial respiratory chain of Ehrlich ascites carcinoma cells by methylglyoxal. Biochem J 303:69-72, 1994
24. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R: Subcellular creatine kinase alterations: implications in heart failure. Circ Res 85:68-76, 1999
25. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R: Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551:491-501, 2003
26. Scholz TD, Koppenhafer SL, TenEyck CJ, Schutte BC: Developmental regulation of the alpha-glycerophosphate shuttle in porcine myocardium. J Mol Cell Cardiol 29:1605-1613, 1997
27. Moreno-Sanchez R, Hansford RG: Dependence of cardiac mitochondrial pyruvate dehydrogenase activity on intramitochondrial free Ca2+ concentration. Biochem J 256:403-412, 1988
28. Petit JM, Maftah A, Ratinaud MH, Julien R: 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 209:267-273, 1992
29. Rousseau D, Helies Toussaint C, Moreau D, Raederstorff D, Grynberg A: Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo. Am J Physiol 285:H1294-H1302, 2003
30. Fry M, Green DE: Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. Biochem Biophys Res Commun 93:1238-1246, 1980
31. Ohtsuka T, Nishijima M, Suzuki K, Akamatsu Y: Mitochondrial dysfunction of a cultured Chinese hamster ovary cell mutant deficient in cardiolipin. J Biol Chem 268:22914-22919, 1993
32. Cao J, Liu Y, Lockwood J, Burn P, Shi Y: A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J Biol Chem 279:31727-31734, 2004
33. Hatch GM: Cell biology of cardiac mitochondrial phospholipids. Biochem Cell Biol 82:99-112, 2004
34. Ponsot E, Zoll J, N'Guessan B, Ribera F, Lampert E, Richard R, Veksler V, Ventura-Clapier R, Mettauer B: Quantitative and qualitative mitochondrial adaptations of substrates utilizations in rat cardiac and skeletal muscles. J Cell Physiol 203:479-486, 2005
35. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839, 1998
36. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, Shulman GI: AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A 99:15983-15987, 2002
37. Saks VA, Khuchua ZA, Vasilyeva EV, Belikova OY, Kuznetsov AV: Metabolic compartmentation and substrate channelling in muscle cells: role of coupled creatine kinases in in vivo regulation of cellular respiration-a synthesis. Mol Cell Biochem 133:155-192, 1994
38. Wicks KL, Hood DA: Mitochondrial adaptations in denervated muscle: relationship to muscle performance. Am J Physiol 260:C841-C850, 1991
39. Schlame M, Rua D, Greenberg ML: The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39:257-288, 2000
40. Heron C, Corina D, Ragan CI: The phospholipid annulus of mitochondrial NADH-ubiquinone reductase: a dual phospholipid requirement for enzyme activity. FEBS Lett 79:399-403, 1977
41. Schagger H, Hagen T, Roth B, Brandt U, Link TA, von Jagow G: Phospholipid specificity of bovine heart bc1 complex. Eur J Biochem 190:123-130, 1990
42. Muller M, Moser R, Cheneval DCE: Cardiolipin is the membrane receptor for mitochondrial creatine phosphokinase. J Biol Chem 260:3829-3843, 1985
43. Xu Y, Sutachan JJ, Plesken H, Kelley RI, Schlame M: Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab Invest 85:823-830, 2005
44. Jiang YJ, Lu B, Xu FY, Gartshore J, Taylor WA, Halayko AJ, Gonzalez FJ, Takasaki J, Choy PC, Hatch GM: Stimulation of cardiac cardiolipin biosynthesis by PPARalpha activation. J Lipid Res 45:244-252, 2004
45. Taylor WA, Xu FY, Ma BJ, Mutter TC, Dolinsky VW, Hatch GM: Expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart. BMC Biochem 3: 9, 2002
46. Han X, Yang J, Cheng H, Yang K, Abendschein DR, Gross RW: Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 44:16684-16694, 2005